查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1613041

可待因市场：按配方、等级、应用、分销管道、最终用户划分 - 2025-2030 年全球预测

Codeine Market by Formulation (Capsule, Syrup, Tablet), Grade (Laboratory Grade, Pharmaceutical Grade), Application, Distribution Channel, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年可待因市场价值为39.3亿美元，预计到2024年将达到41.1亿美元，复合年增长率为4.65%，预计到2030年将达到54亿美元。

可待因是鸦片剂，由于其广泛的用途和疼痛管理的需要，在製药业中发挥着重要作用。可待因主要涵盖处方药和非处方药，如锭剂、胶囊和糖浆。可待因的需求源自于其缓解轻度至中度疼痛的功效以及抑制咳嗽的效用。就用途而言，可待因被医疗保健提供者用于多种治疗目的，主要透过药房和医院分销。最终用途范围还包括需要疼痛管理的患者，创造了持续的需求，推动市场成长。影响成长的关键因素包括慢性疼痛疾病发病率的增加、对疼痛管理解决方案的需求增加以及对有效治疗方案的认识不断提高。然而，潜在的滥用和监管限制对市场成长构成挑战并引起关注。阿片类药物危机导致监管加强，这对扩张产生了负面影响。然而，在开发更安全、成瘾性较低的可待因製剂以及探索可待因衍生物的替代天然来源方面存在新的商机。此外，製剂设计的潜在技术进步可以增强药物传递方法并提供竞争优势。创新还可以集中于改进合成生物技术，以更永续地生产可待因。研究罂粟植物的基因改造及其生物合成途径可能为可待因生产效率提供新的见解。市场相关人员还可以从投资病患教育计画中受益，以提高安全使用意识，建立忠实的消费者基础，同时解决社会问题。这些策略加上遵守不断变化的法律环境，可能会增强市场影响力并确保永续成长。

主要市场统计
基准年[2023] 39.3亿美元
预计年份 [2024] 41.1亿美元
预测年份 [2030] 54亿美元
复合年增长率（%） 4.65%

市场动态：揭示快速发展的可待因市场的关键市场洞察

可待因市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性疼痛和咳嗽的盛行率增加
    • 提供结构化法规结构以确保受管制物质的安全分配
  • 市场限制因素
    • 可待因的生产和商业化成本高
  • 市场机会
    • 药厂与科研机构合作开发可待因创新且高效使用
    • 控制释放製剂不断进步
  • 市场挑战
    • 使用可待因的仿冒品盛行

波特的五力：驾驭可待因市场的策略工具

波特的五力架构是了解可待因市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解对可待因市场的外部影响

外部宏观环境因素在塑造可待因市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解可待因市场的竞争状况

对可待因市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵可待因市场供应商绩效评估

FPNV 定位矩阵是评估可待因市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了可待因市场的成功之路

可待因市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性疼痛和咳嗽症状加重
      • 存在结构化的法规结构，以确保受管制物质的安全流动
    • 抑制因素
      • 可待因的生产和商业化成本很高。
    • 机会
      • 药厂与科研机构联合研发的可待因创新高效使用
      • 控制释放的进展
    • 任务
      • 假冒可待因仿冒品的传播
  • 市场区隔分析
    • 处方：由于患者依从性较高，糖浆优于其他製剂
    • 用途：可待因，被认为是呼吸道疾病咳嗽反射的抑制剂
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 可待因处方市场

  • 胶囊
  • 糖浆
  • 锭剂

第七章可待因市场：依等级

  • 实验室级
  • 医药级

第八章可待因市场：依应用分类

  • 止咳药
  • 抑制腹泻
  • 疼痛管理

第九章可待因市场：依分销管道划分

  • 离线
    • 医院/诊所
    • 药局
  • 在线的

第 10 章 可待因市场：依最终使用者分类

  • 成人
  • 小儿科

第十一章美洲可待因市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区可待因市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的可待因市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 强效镇痛药的开发进展
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Accord Healthcare by Intas Pharmaceuticals
  • Advik Pharma
  • AstraEureka Pharmaceuticals
  • Bristol Laboratories Limited
  • Crescent Pharma Limited
  • Johnson Matthey Plc
  • Noramco, Inc.
  • Omnica Laboratories
  • Pfizer Inc.
  • Professional Compounding Centers of America, Inc.
  • SANOFI WINTHROP INDUSTRIE
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-99555D550530

The Codeine Market was valued at USD 3.93 billion in 2023, expected to reach USD 4.11 billion in 2024, and is projected to grow at a CAGR of 4.65%, to USD 5.40 billion by 2030.

Codeine, an opiate used to treat pain, cough, and diarrhea, plays a crucial role in the pharmaceutical industry due to its widespread application and necessity in pain management. The scope of codeine encompasses prescription and over-the-counter medications, predominantly in the form of tablets, capsules, and syrups. The necessity of codeine stems from its efficacy in providing relief for mild to moderate pain and its utility in suppressing coughs. In terms of application, codeine is utilized by healthcare providers for diverse therapeutic purposes and is primarily distributed through pharmacies and hospitals. The end-use scope includes patients requiring pain management, creating a constant demand that drives market growth. Key factors influencing growth include an increasing incidence of chronic pain conditions, which elevate the demand for pain management solutions, and heightened awareness of effective treatment options. However, the market is gaining attention due to potential misuse and regulatory limitations which challenge its growth. The opioid crisis has led to stricter regulations, negatively impacting expansion. Nevertheless, an emerging opportunity lies in developing safer, less addictive codeine formulations and exploring alternative natural sources for codeine derivatives. Furthermore, potential technological advancements in pharmaceutical formulation design could enhance drug delivery methods, providing a competitive edge. Innovation may also focus on improving synthetic biology techniques to produce codeine more sustainably. Researching genetic modifications in poppy plants or their biosynthetic pathways could yield new insights into codeine production efficiency. Market players can also benefit from investing in patient education programs to enhance safe use awareness, thus creating a loyal consumer base while addressing societal concerns. These strategies, combined with adherence to evolving legal landscapes, could strengthen market presence and ensure sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 3.93 billion
Estimated Year [2024] USD 4.11 billion
Forecast Year [2030] USD 5.40 billion
CAGR (%) 4.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Codeine Market

The Codeine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic pain and cough conditions
    • Availability of structured regulatory frameworks to ensure the safe distribution of controlled substances
  • Market Restraints
    • High costs of production and commercialization of codeine
  • Market Opportunities
    • Collaborative developments between pharmaceutical and research institutions to innovative and efficient uses of codeine
    • Rising advancements in controlled-release formulations
  • Market Challenges
    • Prevalence of counterfeit products with codeine

Porter's Five Forces: A Strategic Tool for Navigating the Codeine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Codeine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Codeine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Codeine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Codeine Market

A detailed market share analysis in the Codeine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Codeine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Codeine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Codeine Market

A strategic analysis of the Codeine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Codeine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accord Healthcare by Intas Pharmaceuticals, Advik Pharma, AstraEureka Pharmaceuticals, Bristol Laboratories Limited, Crescent Pharma Limited, Johnson Matthey Plc, Noramco, Inc., Omnica Laboratories, Pfizer Inc., Professional Compounding Centers of America, Inc., SANOFI WINTHROP INDUSTRIE, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Codeine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Formulation, market is studied across Capsule, Syrup, and Tablet.
  • Based on Grade, market is studied across Laboratory Grade and Pharmaceutical Grade.
  • Based on Application, market is studied across Cough Suppression, Diarrhea Suppression, and Pain Management.
  • Based on Distribution Channel, market is studied across Offline and Online. The Offline is further studied across Hospitals & Clinics and Pharmacies.
  • Based on End-User, market is studied across Adults and Pediatrics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic pain and cough conditions
      • 5.1.1.2. Availability of structured regulatory frameworks to ensure the safe distribution of controlled substances
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of production and commercialization of codeine
    • 5.1.3. Opportunities
      • 5.1.3.1. Collaborative developments between pharmaceutical and research institutions to innovative and efficient uses of codeine
      • 5.1.3.2. Rising advancements in controlled-release formulations
    • 5.1.4. Challenges
      • 5.1.4.1. Prevalence of counterfeit products with codeine
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Formulation: Syrup preferred over other formulations owing to higher patient compliance
    • 5.2.2. Applications: Codeine recognized as a suppressor of cough reflex in respiratory conditions
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Codeine Market, by Formulation

  • 6.1. Introduction
  • 6.2. Capsule
  • 6.3. Syrup
  • 6.4. Tablet

7. Codeine Market, by Grade

  • 7.1. Introduction
  • 7.2. Laboratory Grade
  • 7.3. Pharmaceutical Grade

8. Codeine Market, by Application

  • 8.1. Introduction
  • 8.2. Cough Suppression
  • 8.3. Diarrhea Suppression
  • 8.4. Pain Management

9. Codeine Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
    • 9.2.1. Hospitals & Clinics
    • 9.2.2. Pharmacies
  • 9.3. Online

10. Codeine Market, by End-User

  • 10.1. Introduction
  • 10.2. Adults
  • 10.3. Pediatrics

11. Americas Codeine Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Codeine Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Codeine Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Advancements in Developing Enhanced Pain Relief Medications
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Accord Healthcare by Intas Pharmaceuticals
  • 3. Advik Pharma
  • 4. AstraEureka Pharmaceuticals
  • 5. Bristol Laboratories Limited
  • 6. Crescent Pharma Limited
  • 7. Johnson Matthey Plc
  • 8. Noramco, Inc.
  • 9. Omnica Laboratories
  • 10. Pfizer Inc.
  • 11. Professional Compounding Centers of America, Inc.
  • 12. SANOFI WINTHROP INDUSTRIE
  • 13. Sun Pharmaceutical Industries Ltd.
  • 14. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. CODEINE MARKET RESEARCH PROCESS
  • FIGURE 2. CODEINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CODEINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CODEINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CODEINE MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CODEINE MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CODEINE MARKET SIZE, BY GRADE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CODEINE MARKET SIZE, BY GRADE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CODEINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CODEINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CODEINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CODEINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CODEINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CODEINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CODEINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CODEINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CODEINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CODEINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CODEINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CODEINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CODEINE MARKET DYNAMICS
  • TABLE 7. GLOBAL CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CODEINE MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CODEINE MARKET SIZE, BY SYRUP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CODEINE MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CODEINE MARKET SIZE, BY LABORATORY GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CODEINE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CODEINE MARKET SIZE, BY COUGH SUPPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CODEINE MARKET SIZE, BY DIARRHEA SUPPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CODEINE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CODEINE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CODEINE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CODEINE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CODEINE MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CODEINE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CODEINE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CODEINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES CODEINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CODEINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH KOREA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. TAIWAN CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. THAILAND CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. VIETNAM CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 151. DENMARK CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. EGYPT CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. FINLAND CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. FRANCE CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. GERMANY CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. ISRAEL CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. ITALY CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. NETHERLANDS CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. NIGERIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. NORWAY CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. POLAND CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. QATAR CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. RUSSIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. SAUDI ARABIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH AFRICA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. SPAIN CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 247. SWEDEN CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. SWITZERLAND CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. TURKEY CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. UNITED ARAB EMIRATES CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED KINGDOM CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 277. CODEINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 278. CODEINE MARKET, FPNV POSITIONING MATRIX, 2023